EN PL

FDA: E16 Genomic Biomarkers Related to Drug Response: Context, Structure, and Format of Qualification Submissions

31.07.2009
The guideline describes recommendations regarding context, structure, and format of regulatory submissions for qualification of genomic biomarkers, as defined in ICH E15. Biomarker qualification has not been covered in any ICH guideline. Qualification is a conclusion that the biomarker data submitted support use of the biomarker in drug discovery, development or post-approval and, where appropriate, in regulatory decision-making.